MacroGenics: Q2 Earnings Snapshot

August 8, 2022 GMT

ROCKVILLE, Md. (AP) _ MacroGenics Inc. (MGNX) on Monday reported a loss of $41.3 million in its second quarter.

On a per-share basis, the Rockville, Maryland-based company said it had a loss of 67 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 97 cents per share.

The biopharmaceutical company posted revenue of $26 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $14.6 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on MGNX at